Publications

1 - 5 of 5 results

Search term:

Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, a Vrije Universiteit Brussel

Yvan Vandenplas
OBJECTIVE: To develop a North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) international consensus on the diagnosis and management of gastroesophageal reflux and gastroesophageal reflux disease in the pediatric population.

METHODS: An international panel of 9 pediatric gastroenterologists and 2 ...

Endoscopy in pediatric inflammatory bowel disease : a position paper on behalf of the Porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Ghent University

Salvatore Oliva, Mike Thomson, Lissy de Ridder, Javier Martín-de-Carpi, Stephanie Van Biervliet, Christian Braegger, Jorge Amil Dias, Sanja Kolacek, Erasmo Miele, Stephan Buderus, et al.
Endoscopy is a central tool for the evaluation and management of inflammatory bowel disease (IBD). In the last few decades, gastrointestinal (GI) endoscopy has undergone significant technological developments including availability of pediatric-size equipment, enabling comprehensive investigation of the GI tract in children. Simultaneously, professional organization of GI experts have developed guidelines and training programs in pediatric GI ...

Public private collaboration in clinical research during pregnancy, lactation and childhood. A joint position statement of the early nutrition academy (ENA) and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Vrije Universiteit Brussel

B. Koletzko, M. Benninga, K. Godfrey, P. Hornnes, Yvan Vandenplas, Geneviève Veereman
This position statement summarises a view of academia regarding standards for clinical research in collaboration with commercial enterprises, focussing on trials in pregnant women, breastfeeding women and children. It is based on a review of the available literature and an expert workshop co-sponsored by the Early Nutrition Academy and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Clinical research ...

Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients? (Reprinted from Journal of Gastroenterology and Hepatology, vol 61, pg 1501-9, 2012 ) KU Leuven

Guy Boeckxstaens
Treatment modalities for gastro-oesophageal reflux disease (GORD) mirror the pathophysiology of the disease. Since acid plays a key role in GORD-associated mucosal lesions, proton pump inhibitors (PPIs) are the dominant GORD treatment, being the most potent inhibitors of acid secretion available. However, the clinical effectiveness of PPIs varies with the specific symptoms being treated; they are more effective for heartburn than for ...

Plant-based sterols and stanols in health & disease: "Consequences of human development in a plant-based environment?" Hasselt University

J. Plat, S. Baumgartner, Tim VANMIERLO, D. Luetjohann, K. L. Calkins, D. G. Burrin, G. Guthrie, C. Thijs, A. A. Te Velde, A. C. E. Vreugdenhil, et al.
Dietary plant sterols and stanols as present in our diet and in functional foods are well-known for their inhibitory effects on intestinal cholesterol absorption, which translates into lower low-density lipoprotein cholesterol concentrations. However, emerging evidence suggests that plant sterols and stanols have numerous additional health effects, which are largely unnoticed in the current scientific literature. Therefore, in this review we ...